[11C]Cimbi-36
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [11C]Cimbi-36, covering 2024-10-09 to 2024-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors [NA]